In an interesting study, methylenetetrahydrofolate reductase (MTHFR) C677T was statistically significant in thrombotic patients with MPN compared with the general thrombosis population by both univariate (p = 0.001) and multiple regression analyses (p = 0.01). This evidence concerns the gene MTHFR and myeloproliferative neoplasm.